Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 210

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 6
Chunk 210
---
 employment. The enforceability of covenants not to compete in Israel and in the United States is subject to limitations. The employment agreement of each executive officer is terminable upon between 30 to 90 days’ written notice by either party to the agreement.
 

Director Compensation
 
Our directors are entitled to cash compensation and equity compensation as follows:
 
Cash Compensation of Directors
 
All of our directors receive annual fees and per-meeting fees for their service on our board and its committees, in the following amounts:
 

◾   Annual fees in an amount of approximately $24,000 for directors classified as experts; and
----------------------------------------------------------------------------------------------

◾   Per-meeting fees in an amount of approximately $1,300 for directors classified as experts; 60% of such amounts for participation
                     in meetings via telecommunication and 50% of such amounts for resolutions adopted in writing.                  
------------------------------------------------------------------------------------------------------------------------------------
 
Such amounts are within the range for cash compensation for external and unaffiliated directors of a company of our size (based on level of shareholders’ equity) under the Companies Law.
 
Cash Compensation of Chairperson of the Board
 
In accordance with shareholders’ approval from August 2021, a chairperson of the board who is determined by the Board to be an “active chairperson” in light of increased involvement in our activities and increased time investment in the performance of the duties accompanying the chairperson’s position compared to the other directors, shall be entitled to increased compensation relative to our other directors of approximately $6,600 per month. Our Board has determined that Mr. Nir Nimrodi, our chairperson of the board, is an active chairperson, and accordingly his fees as active chairperson is as aforesaid.
 
Equity Compensation of Directors
 
In accordance with our shareholders’ approval from August 2021, and in compliance with our compensation policy, each non-employee director is granted options to purchase 18,000 ordinary shares of the Company on the date of our annual general shareholders meeting at which such director is elected or re-elected to the board. The chairperson of our board is granted options to purchase 36,000 ordinary shares. These options vest over a period of one year, with 25% of the options vesting at the end of each successive three-month period following the director’s appointment or re-appointment (as applicable) by the general meeting of shareholders, subject to continued service through each vesting date.  In the case of a director who is elected to the Board for the first